Skip to main content



Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.
Dr Philip Low of On Target Laboratories discusses OTL38, a novel, tumor-targeted dye used to guide cancer surgery.
Clinical Insights
We report one of the first cases of successful treatment of vertebral fractures due to metastasis by using the SpineJack System.
Dr Riad Salem discusses the pros and cons of streamlining Y90 in UNOS T1/T2 by eliminating the lung shunting study.
Dr Eric Soule presents a "CIO Best Abstract" on OX40, a receptor that causes T-cells to divide, increasing their ability to attack cancer.
Back to Top